|
Federal Register
Notices
> Manufacturers 2008 >
AMRI Rensselaer, Inc.
FR Doc E8-22876[Federal Register: September 29, 2008 (Volume 73, Number 189)]
[Notices] [Page 56612] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr29se08-105]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated May 19, 2008 and published in the Federal Register on May 27,
2008 (73 FR 30418), AMRI Rensselaer, Inc., 33 Riverside Avenue, Rensselaer, New
York 12144, made application by renewal to the Drug Enforcement Administration (DEA)
to be registered as a bulk manufacturer of the basic classes of controlled
substances listed in schedule I and II:
|
Drug
|
Schedule
|
|
Marihuana (7360)
|
I
|
|
Tetrahydrocannabinols (7370)
|
I
|
|
Amphetamine (1100)
|
II
|
|
Lisdexamfetamine (1205)
|
II
|
|
Methylphenidate (1724)
|
II
|
|
Pentobarbital (2270)
|
II
|
|
Hydrocodone (9193)
|
II
|
|
Meperidine (9230)
|
II
|
|
Dextropropoxyphene, bulk (non-dosage form)(9273)
|
II
|
|
Oxymorphone (9652)
|
II
|
|
Fentanyl (9801)
|
II
|
The company plans to manufacture bulk controlled substances for use in
product development and for distribution to its customers. In reference to drug
code 7360 (Marihuana), the company plans to bulk manufacture cannabidiol as a
synthetic intermediate. This controlled substance will be further synthesized to
bulk manufacture a synthetic THC (7370). No other activity for this drug code is
authorized for this registration. No comments or objections have been received.
DEA has considered the factors in 21 U.S.C. 823(a) and determined that the
registration of AMRI Rensselaer, Inc. to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this time. DEA
has investigated AMRI Rensselaer, Inc. to ensure that the company's registration
is consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems, verification
of the company's compliance with state and local laws, and a review of the
company's background and history. Therefore, pursuant to 21
U.S.C. 823, and in
accordance with 21 CFR
1301.33, the above named company is granted registration
as a bulk manufacturer of the basic classes of controlled substances listed.
Dated: September 22, 2008.
Joseph T. Rannazzisi,
Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR
Doc. E8-22876 Filed 9-26-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|